In the last 40 years, advances in protein engineering and evolution have prompted the application of biocatalysts in the synthesis of active pharmaceutical ingredients (API), as well as fine and bulk chemicals for the agrochemical, food, biofuel, and pharmaceutical industries.
Computational chemistry methodologies in conjunction with smart variant library generation and high-throughput screening are fueling the development of a new generation of rationally designed biocatalysts with enhanced selectivity and specificity at a fraction of the time and cost of what was achievable a mere decade ago.
Join our webinar with Dr. Derek Quinn, Senior Biology Team Leader for Biocatalysis at Almac Sciences, to:
- Learn how novel biocatalysts can be identified using bioinformatics, in silico design, gene synthesis, and rapid screening.
- Hear how the best candidate enzymes can then be further improved by engineering/evolution.
- Review several case studies showcasing this approach.
- See how Almac is leveraging Twist’s scalable DNA synthesis platform to power these projects with many hundreds of genes.